Skip to main content
Livermore
Livermore
ZHEN

Precision Biosciences Inc

DTIL
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001357874

No open-market purchases or sales by Precision Biosciences Inc insiders were filed in the last 90 days; 95 institutions reported holding it in 13F filings for Q2 2026, worth $138.9M in total; no superinvestor holds it.

Holders of 5% or more of DTIL

Holders whose latest Schedule 13D or 13G filing reports 5% or more of Precision Biosciences Inc, largest stake first. The change is against the holder's previous filing.

Holders of 5% or more of DTIL
HolderLatest formStakeChangeFirst filedLatest filingFiling
Octagon Capital Advisors LP13G9.99%2.33M sharesNewFeb 10, 20261 filingFeb 10, 2026SEC
Empery Asset Management, LP13G9.99%2.30M sharesNewJan 22, 20261 filingJan 22, 2026SEC
Readout Capital, LP13G/A9.40%1.12M shares+0.50 ppfrom 8.90%Mar 26, 20252 filingsAug 14, 2025SEC
Standard Life Aberdeen plc13G8.88%2.14M sharesNewJan 27, 20261 filingJan 27, 2026SEC
Bleichroeder LP13G/A8.21%1.90M shares−1.48 ppfrom 9.69%Aug 14, 20252 filingsFeb 13, 2026SEC
Weinstein Benjamin13G5.20%395.5K sharesNewMar 18, 20251 filingMar 18, 2025SEC

Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.

13D and 13G filings

19 Schedule 13D and 13G filings on Precision Biosciences Inc, newest first, including old-format filings without a stake.

Schedule 13D and 13G filings on DTIL
Filed (ET)FilerFormStakeChangeEvent dateFiling
Feb 17, 20264:15 PM ETTang Capital Management LLCand 5 others13G/A0.00%0 shares−6.40 ppfrom 6.40%Below 5%Dec 31, 2025SEC
Feb 17, 20261:46 PM ETLynx1 Capital Management LPand 1 other13G/A4.10%993.9K shares−4.70 ppfrom 8.80%Below 5%Dec 31, 2025SEC
Feb 13, 20264:44 PM ETBleichroeder LPand 2 others13G/A8.21%1.90M shares−1.48 ppfrom 9.69%Dec 31, 2025SEC
Feb 10, 20261:15 PM ETOctagon Capital Advisors LPand 2 others13G9.99%2.33M sharesNewDec 31, 2025SEC
Jan 27, 202610:10 AM ETStandard Life Aberdeen plcand 1 other13G8.88%2.14M sharesNewDec 31, 2025SEC
Jan 22, 20261:01 PM ETEmpery Asset Management, LPand 1 other13G9.99%2.30M sharesNewDec 31, 2025SEC
Nov 14, 20252:02 PM ETLynx1 Capital Management LPand 1 other13G/A8.80%1.04M shares−1.19 ppfrom 9.99%Sep 30, 2025SEC
Aug 14, 20254:09 PM ETReadout Capital, LPand 4 others13G/A9.40%1.12M shares+0.50 ppfrom 8.90%Jun 30, 2025SEC
Aug 14, 202511:14 AM ETBleichroeder LPand 2 others13G9.69%1.07M sharesNewJun 30, 2025SEC
Aug 6, 20254:48 PM ETAquilo Capital Management, LLCand 2 others13G/A0.00%0 shares−9.90 ppfrom 9.90%Below 5%Jun 30, 2025SEC
Aug 6, 20254:01 PM ETNovartis Pharma AGand 1 other13G/A3.70%413.6K shares−1.70 ppfrom 5.40%Below 5%Jun 30, 2025SEC
May 15, 20254:15 PM ETTang Capital Management LLCand 5 others13G/A6.40%673.3K shares–Mar 31, 2025SEC
Apr 25, 20252:16 PM ETHighbridge Capital Management LLC13G/A3.70%406.3K shares–Below 5%Mar 31, 2025SEC
Mar 26, 20256:09 PM ETReadout Capital, LPand 4 others13G8.90%932.9K sharesNewMar 19, 2025SEC
Mar 18, 20255:13 PM ETWeinstein Benjamin13G5.20%395.5K sharesNewMar 18, 2025SEC
Feb 14, 202511:59 AM ETAquilo Capital Management, LLCand 2 others13G/A9.90%791.9K shares–Dec 31, 2024SEC
Feb 14, 202511:35 AM ETJanus Henderson Group PLC13G/A0.00%0 shares–Below 5%Dec 31, 2024SEC
Feb 14, 20259:01 AM ETLynx1 Capital Management LPand 1 other13G9.99%766.1K sharesNewDec 31, 2024SEC
Feb 12, 20255:00 PM ETNovartis Pharma AGand 1 other13G/A5.40%413.6K shares–Dec 31, 2024SEC

Form 144: proposed insider sales

Notices from officers, directors and other affiliates planning to sell Precision Biosciences Inc shares.

No Form 144 notices for Precision Biosciences Inc are on file.